Complications in Primary and Completed Thyroidectomy
Overview
Affiliations
Purpose: To compare the rates of postsurgical complications following a primary and completed thyroidectomy for multinodular goiter (MNG).
Methods: A total of 7123 cases of thyroidectomy in two hospitals from 1990 to 2007 (n = 3834 [53.83%] total [TT], n = 2238 [31.42%] subtotal [ST], and n = 1051 [14.75%] hemithyroidectomy [HT]) were studied for complications. The follow-up checked for injury of the laryngeal nerves, hypoparathyroidism, pathology recurrence, and appearance of neoplasm.
Results: Postoperative mean follow-up: 7 years 9 months Primary operation: permanent recurrent laryngeal nerve (RLN) injury was observed in 1.4% in the TT group, 1.2% in the ST, and 0.9% in the HT group (P > 0.1 vs ST and TT). Permanent hypocalcaemia: 3.5% in TT group, 2.5% in the ST, in 1.4% in the HT. Eight hundred and seventy-seven patients suffered recurrence of MNG (n = 482 after ST, n = 395 after HT). Five hundred and sixty-four recurrent cases required a completion thyroidectomy. Reoperations: Permanent RLN injury was observed in 3% in the post-ST group and 2.5% in the post-HT group. Permanent hypocalcemia: 5.9% in the post-ST group and 4% in the post-HT group.
Conclusion: There is no significant difference in complications between a primary TT and ST. The rates of complications after a completed thyroidectomy are significantly higher in comparison with the primary operations. High rates of reoperation in cases of recurrent pathology and incidental carcinoma were reported.
Kim K, Chai Y, Han M, Kang S, Yun J Ann Surg Treat Res. 2025; 108(2):71-78.
PMID: 39944927 PMC: 11813551. DOI: 10.4174/astr.2025.108.2.71.
Faro F, Bertelli A, Scalissi N, Cury A, Padovani R, Ferraz C Arch Endocrinol Metab. 2024; 68:e230349.
PMID: 39420891 PMC: 11326739. DOI: 10.20945/2359-4292-2023-0349.
Papini E, Crescenzi A, DAmore A, Deandrea M, De Benedictis A, Frasoldati A Endocr Metab Immune Disord Drug Targets. 2023; 23(6):876-885.
PMID: 36722479 PMC: 10245801. DOI: 10.2174/1871530323666230201104112.
Barua S, Yadav S, Aggarwal V, Mishra A, Mishra S, Chand G South Asian J Cancer. 2022; 11(2):152-155.
PMID: 36466987 PMC: 9718605. DOI: 10.1055/s-0041-1739177.
Zhang F, Zheng B, Yu X, Wang X, Wang S, Teng W Front Endocrinol (Lausanne). 2021; 12:675643.
PMID: 34322091 PMC: 8310921. DOI: 10.3389/fendo.2021.675643.